(N04.4) Nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis

More details coming soon

Icon
1 288 076 in individuals diagnosis nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis confirmed
Icon
9 412 deaths with diagnosis nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis
Icon
1% mortality rate associated with the disease nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis

Diagnosis nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis is diagnosed Men are 19.20% more likely than Women

767 701

Men receive the diagnosis nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis

4 730 (0.6 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
520 375

Women receive the diagnosis nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis

4 682 (0.9 %)

Died from this diagnosis.

Risk Group for the Disease nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis - Men and Women aged 5-9

Icon
In Men diagnosis is most often set at age 0-94
Icon
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 95+
Icon
In Women diagnosis is most often set at age 0-94

Disease Features nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis

Icon
Absence or low individual and public risk
Icon

Nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis - what does this mean

Nephrotic syndrome is caused by diffuse endocapillary proliferative glomerulonephritis, a condition in which the glomeruli (the tiny filters in the kidneys) become inflamed and begin to leak proteins and other substances into the urine. this leads to swelling in the body, proteinuria, and other complications.

What happens during the disease - nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis

Nephrotic syndrome is caused by diffuse endocapillary proliferative glomerulonephritis, a type of glomerulonephritis. this condition is characterized by inflammation and thickening of the glomerular capillaries, leading to the disruption of the normal filtration of the glomerulus. this disruption leads to an increase in the amount of protein in the urine, as well as an increase in the amount of water and electrolytes lost in the urine. as a result, the patient experiences swelling, proteinuria, and hypoalbuminemia.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete blood count (CBC)
  • Serum albumin
  • Serum cholesterol
  • Serum triglycerides
  • Urinalysis
  • Urine protein/creatinine ratio
  • Kidney biopsy
  • Imaging studies such as ultrasound or CT scan
  • Renal function tests
  • Immunological tests
  • Renal biopsy

Treatment and Medical Assistance

Main Goal of the Treatment: To reduce proteinuria, edema, and risk of complications
  • Prescribe corticosteroids or other immunosuppressants to reduce inflammation
  • Monitor blood pressure and treat hypertension
  • Prescribe diuretics to reduce edema
  • Prescribe ACE inhibitors or angiotensin receptor blockers to reduce proteinuria
  • Monitor kidney function and urine protein levels to detect signs of progression
  • Prescribe anticoagulants to reduce risk of thrombosis
  • Prescribe antibiotics to treat infections
  • Prescribe antihypertensives to reduce blood pressure
  • Prescribe lipid-lowering drugs to reduce risk of cardiovascular disease
  • Provide patient education and lifestyle advice to reduce risk of complications
Icon
14 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Nephrotic syndrome : diffuse endocapillary proliferative glomerulonephritis - Prevention

Nephrotic syndrome is best prevented through early diagnosis and management of underlying conditions, such as diabetes, hypertension, and infections. additionally, maintaining a healthy lifestyle, including regular exercise and a balanced diet, can help reduce the risk of developing this condition.